KZR
Kezar Life Sciences·NASDAQ
--
--(--)
--
--(--)
4.58 / 10
Netural
Fund flow evaluation: 7.08/10 reflecting robust fund flow characteristics. Constructive overall, block, Medium, Large, and Extra-large trends face headwinds from adverse Small developments, indicating positive money flow direction. Analyst consensus points to divided analyst consensus with neutral perspective. Distribution analysis: Neutral(100.0%) among 3 research opinions, supported by 2.08 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-17
InstitutionWells Fargo
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for KZR?
- KZR holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.58/10 (Netural).
